Cell Pathways continues to investigate apoptosis-promoting compounds for neoplastic diseases Sep. 14, 1999 No Comments
MS-275: new benzamide inhibitor of histone deacetylase selected as development candidate Sep. 14, 1999 No Comments
U.S. and Canadian academics design novel prodrug approach to 5-FU chemotherapy Sep. 10, 1999 No Comments
Israeli group designs new family of nonpeptide, nonsulfhydryl Ras farnesylation inhibitors Sep. 9, 1999 No Comments
Atairgin and Washington State University to develop new therapeutic applications Sep. 9, 1999 No Comments
RSS